Market revenue in 2023 | USD 362.6 million |
Market revenue in 2030 | USD 634.3 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Immunohistochemistry |
Fastest growing segment | Digital Pathology and Workflow |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 25.7% in 2024. Horizon Databook has segmented the France tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
France being the second biggest healthcare market after Germany is expected to possess a tremendous potential for the introduction and commercialization of newer technologies. Market is expected to witness a good growth in the forecast period owing the number of research facilities and pharmaceutical companies which are into the development and introduction of newer and reliable technology.
Other factors such as government aid, reimbursement regulations being set are too expected to propel the market growth as favorable reimbursement rules would encourage higher adoption of these technologies.
Biotechnology companies have step up with precision medicine technologies in the recent times and this is expected to change the market landscape and push for higher demand of better sequencing and diagnostic technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the France tissue diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into France tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account